Home » Topics » Regulatory » Patents

Patents
RSS

Novel Raf kinase inhibitors described by Novartis for the treatment of cancer

Dec. 31, 2009

Novel HDAC inhibitors being developed by EnVivo Pharmaceuticals and MethylGene

Dec. 31, 2009

Pim kinase inhibitors claimed by Novartis for the treatment of cancer

Dec. 31, 2009

Esteve discloses 5-HT6 receptor ligands for the treatment of eating disorders

Dec. 31, 2009

Novel Raf kinase inhibitors presented by Wyeth as oncolytics

Dec. 31, 2009

Freie Universitaet Berlin claims novel pepstatin A derivatives

Dec. 31, 2009

GSK identifies 5-HT2B receptor antagonists for fibrotic conditions and IBS

Dec. 30, 2009

Gilead describes SCD inhibitors for the treatment of obesity

Dec. 30, 2009

Lilly identifies CB1 ligands for the treatment of obesity

Dec. 30, 2009

Cathepsin C inhibitors for the treatment of COPD identified by GlaxoSmithKline

Dec. 30, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...